Hiromi Abe

7.6k total citations
170 papers, 6.0k citations indexed

About

Hiromi Abe is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hiromi Abe has authored 170 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 53 papers in Hepatology and 48 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hiromi Abe's work include Hepatitis C virus research (51 papers), Growth Hormone and Insulin-like Growth Factors (39 papers) and Hepatitis B Virus Studies (36 papers). Hiromi Abe is often cited by papers focused on Hepatitis C virus research (51 papers), Growth Hormone and Insulin-like Growth Factors (39 papers) and Hepatitis B Virus Studies (36 papers). Hiromi Abe collaborates with scholars based in Japan, United States and Italy. Hiromi Abe's co-authors include Kazuo Chihara, Kazuaki Chayama, Hidesuke Kaji, Yasuhiko Okimura, Hidenori Ochi, C. Nelson Hayes, Masataka Tsuge, Michio Imamura, Nobuhiko Hiraga and Yutaka Takahashi and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hiromi Abe

168 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromi Abe Japan 43 2.2k 1.8k 1.5k 1.4k 997 170 6.0k
Carl Denef Belgium 41 391 0.2× 460 0.2× 2.4k 1.6× 1.6k 1.2× 878 0.9× 143 5.5k
Masatomo Mori Japan 48 1.4k 0.7× 241 0.1× 2.0k 1.3× 2.0k 1.4× 742 0.7× 263 8.3k
Masanobu Yamada Japan 31 970 0.4× 159 0.1× 632 0.4× 914 0.7× 433 0.4× 190 3.9k
John‐Olov Jansson Sweden 41 1.8k 0.8× 191 0.1× 3.4k 2.2× 1.9k 1.4× 228 0.2× 107 7.5k
Diego J. Walther Germany 21 410 0.2× 318 0.2× 322 0.2× 1.5k 1.1× 1.2k 1.2× 30 4.9k
Alex M. DePaoli United States 58 4.7k 2.1× 700 0.4× 1.9k 1.2× 4.1k 3.0× 307 0.3× 100 12.6k
Christophe Bonny Switzerland 40 578 0.3× 270 0.1× 561 0.4× 3.1k 2.2× 913 0.9× 114 6.3k
P. Kay Lund United States 52 818 0.4× 113 0.1× 2.6k 1.7× 3.1k 2.2× 916 0.9× 132 7.8k
Shoji Fukusumi Japan 26 535 0.2× 135 0.1× 928 0.6× 1.5k 1.1× 2.5k 2.5× 33 6.4k
Yuji Kawamata Japan 19 484 0.2× 135 0.1× 816 0.5× 1.2k 0.9× 2.2k 2.2× 29 5.8k

Countries citing papers authored by Hiromi Abe

Since Specialization
Citations

This map shows the geographic impact of Hiromi Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Abe more than expected).

Fields of papers citing papers by Hiromi Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromi Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Abe. The network helps show where Hiromi Abe may publish in the future.

Co-authorship network of co-authors of Hiromi Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Abe. A scholar is included among the top collaborators of Hiromi Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Abe. Hiromi Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakao, Takafumi, et al.. (2024). Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan. International Journal of Clinical Oncology. 29(7). 932–943.
2.
Takebayashi, Minoru, Hiromi Abe, Chiyo Shibasaki, et al.. (2019). Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder. The International Journal of Neuropsychopharmacology. 22(4). 261–269. 13 indexed citations
3.
Shibasaki, Chiyo, et al.. (2017). Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT). The International Journal of Neuropsychopharmacology. 21(3). 236–241. 17 indexed citations
4.
Kan, Hiromi, Michio Imamura, Takuro Uchida, et al.. (2016). Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing. The Journal of Infectious Diseases. 214(11). 1687–1694. 8 indexed citations
5.
6.
Hayes, C. Nelson, Sakura Akamatsu, Hiromi Abe, et al.. (2013). Circulating microRNA‐22 correlates with microRNA‐122 and represents viral replication and liver injury in patients with chronic hepatitis B. Journal of Medical Virology. 85(5). 789–798. 61 indexed citations
7.
Nakamura, Yoki, Norimitsu Morioka, Hiromi Abe, et al.. (2013). Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1. PLoS ONE. 8(8). e73640–e73640. 75 indexed citations
8.
Hiraga, Nobuhiko, Hiromi Abe, Michio Imamura, et al.. (2011). Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus. Hepatology. 54(3). 764–771. 28 indexed citations
9.
Chayama, Kazuaki, C. Nelson Hayes, Hiromi Abe, et al.. (2011). IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C. The Journal of Infectious Diseases. 204(1). 84–93. 96 indexed citations
10.
Miki, Daiki, Hidenori Ochi, C. Nelson Hayes, et al.. (2011). Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nature Genetics. 43(8). 797–800. 118 indexed citations
11.
Abe, Hiromi, et al.. (2010). Parents' Response to their Sick Child and the Current Status of Sick-Child-Care Support Needs. 19(2). 411–418. 2 indexed citations
12.
Chayama, Kazuaki, C. Nelson Hayes, Nobuhiko Hiraga, et al.. (2010). Animal model for study of human hepatitis viruses. Journal of Gastroenterology and Hepatology. 26(1). 13–18. 43 indexed citations
13.
Hiraga, Nobuhiko, Michio Imamura, Tsuyoshi Hatakeyama, et al.. (2009). Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice. Journal of Hepatology. 51(6). 1046–1054. 26 indexed citations
14.
Hiraga, Nobuhiko, Michio Imamura, Masataka Tsuge, et al.. (2007). Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon. FEBS Letters. 581(10). 1983–1987. 43 indexed citations
15.
Imaizumi, Masamoto, et al.. (2007). Vogt–Koyanagi–Harada disease in elderly Japanese patients. International Ophthalmology. 27(2-3). 149–153. 21 indexed citations
16.
Xu, Yue, Hidesuke Kaji, Yasuhiko Okimura, et al.. (1996). Paracrine Stimulation of Cell Growth by Cholecystokinin/Gastrin through Cholecystokinin-B Receptor on GH<sub>3</sub> Cells in vitro. Neuroendocrinology. 64(4). 280–285. 7 indexed citations
17.
Kaji, Hidesuke, et al.. (1996). No correlation of growth hormone receptor gene mutation P561T with body height. European Journal of Endocrinology. 134(5). 560–562. 26 indexed citations
18.
Murasato, Yoshinobu, et al.. (1994). Complete atrioventricular block during left heart catheterization.. Japanese Circulation Journal. 58(8). 671–675. 4 indexed citations
19.
20.
Kitajima, Naoto, et al.. (1990). Galanin stimulates immunoreactive growth hormone-releasing factor secretion from rat hypothalamic slices perifused in vitro. Life Sciences. 47(25). 2371–2376. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl Denef Breakdown of academic impact, for papers by Masatomo Mori Breakdown of academic impact, for papers by Masanobu Yamada Breakdown of academic impact, for papers by John‐Olov Jansson Breakdown of academic impact, for papers by Diego J. Walther Breakdown of academic impact, for papers by Alex M. DePaoli Breakdown of academic impact, for papers by Christophe Bonny Breakdown of academic impact, for papers by P. Kay Lund Breakdown of academic impact, for papers by Shoji Fukusumi Breakdown of academic impact, for papers by Yuji Kawamata
Rankless by CCL
2026